These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2219343)

  • 1. A pure class II MHC disparity does not induce rejection of cornea or heart grafts in the rat.
    Katami M; Lim SM; Kamada N; Davies HF; Butcher GW; White DJ; Watson PG; Calne RY
    Transplant Proc; 1990 Oct; 22(5):2200-1. PubMed ID: 2219343
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-MHC antigens and their relative resistance to immunosuppression after corneal transplantation.
    Nicholls SM; Bradley BA; Easty DL
    Eye (Lond); 1995; 9 ( Pt 2)():208-14. PubMed ID: 7556719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine orthotopic corneal transplantation in high-risk eyes. Rejection is dictated primarily by weak rather than strong alloantigens.
    Sano Y; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 1997 May; 38(6):1130-8. PubMed ID: 9152232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of class II antigen-expressing cells in corneal allograft immunity.
    Gebhardt BM
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2254-60. PubMed ID: 2242991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corneal transplantation--immunologically privileged status.
    Katami M
    Eye (Lond); 1991; 5 ( Pt 5)():528-48. PubMed ID: 1794420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preservation of donor cornea prevents corneal allograft rejection by inhibiting induction of alloimmunity.
    Kamiya K; Hori J; Kagaya F; Usui T; Amano S; Oshika T; Mizouchi T; Tsuru T; Yamagami S
    Exp Eye Res; 2000 Jun; 70(6):737-43. PubMed ID: 10843778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of major and minor histocompatibility antigens in orthotopic corneal transplantation in mice.
    Hasková Z; Filipec M; Holán V
    Folia Biol (Praha); 1996; 42(3):105-11. PubMed ID: 8971221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific inhibition of heart allograft rejection by serum from liver-grafted rats.
    Kamada N; Shinomiya T; Tamaki T
    Transplant Proc; 1987 Feb; 19(1 Pt 1):570-1. PubMed ID: 3274823
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute rejection of orthotopic corneal xenografts in mice depends on CD4(+) T cells and self-antigen-presenting cells.
    Tanaka K; Sonoda K; Streilein JW
    Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2878-84. PubMed ID: 11687532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An improved method for examining the corneal endothelium during graft rejection in the rat.
    Figueiredo FC; Pendergrast DG; Zhang L; Easty DL; Nicholls SM
    Exp Eye Res; 1998 Dec; 67(6):625-30. PubMed ID: 9990327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of immunodominant donor MHC peptides following rejection and donor strain transfusion-induced tolerance of heart allografts in adult rats.
    van Denderen B; Pêche H; Gagne K; Usal C; Cuturi MC; Soulillou JP
    Eur J Immunol; 2001 May; 31(5):1333-9. PubMed ID: 11465090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The induction of class II antigens by interferon-gamma and its relevance for the acute rejection of allografts.
    IJzermans JN; Bouwman E; de Bruin RW; Marquet RL; Jeekel J
    Transplant Proc; 1987 Feb; 19(1 Pt 1):244-5. PubMed ID: 3152697
    [No Abstract]   [Full Text] [Related]  

  • 13. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model.
    Ito H; Hamano K; Fukumoto T; Wood KJ; Esato K
    J Heart Lung Transplant; 1998 May; 17(5):460-9. PubMed ID: 9628564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of modulation of donor class II antigen expression on the survival of rat cardiac allografts.
    Barron PT; Tyerman K; McLeish M; Thiru S; Collier SJ
    Transplant Proc; 1990 Aug; 22(4):1931-2. PubMed ID: 2117818
    [No Abstract]   [Full Text] [Related]  

  • 15. Survival of MHC-deficient mouse heterotopic cardiac allografts.
    Campos L; Naji A; Deli BC; Kern JH; Kim JI; Barker CF; Markmann JF
    Transplantation; 1995 Jan; 59(2):187-91. PubMed ID: 7839439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A CIITA-independent pathway that promotes expression of endogenous rather than exogenous peptides in immune-privileged sites.
    Arancibia-Cárcamo CV; Osawa H; Arnett HA; Háskova Z; George AJ; Ono SJ; Ting JP; Streilein JW
    Eur J Immunol; 2004 Feb; 34(2):471-80. PubMed ID: 14768052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplantation and the eye.
    Batchelor JR
    Eye (Lond); 1995; 9 ( Pt 2)():v-vi. PubMed ID: 7556707
    [No Abstract]   [Full Text] [Related]  

  • 18. Cytomegalovirus induces class II expression in rat heart endothelial cells.
    Ustinov JA; Loginov RJ; Bruggeman CA; van der Meide PH; Häyry PJ; Lautenschlager IT
    J Heart Lung Transplant; 1993; 12(4):644-51. PubMed ID: 8396436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of donor major histocompatibility complex antigens in coronary arterial vessels: mechanism of arterial vasculitis in rat allografts treated with cyclosporine.
    Herskowitz A; Tamura F; Ueda K; Neumann DA; Slepian M; Rose NR; Beschorner WE; Baumgartner WA; Reitz BR; Sell KW
    J Heart Transplant; 1989; 8(1):11-9. PubMed ID: 2647926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+ T-cell-dependent destruction of MHC class I disparate cardiac allografts.
    Morton AL; Bolton EM; Lawes CM; Porteous C; Bradley JA
    Transplant Proc; 1993 Feb; 25(1 Pt 1):102-3. PubMed ID: 8438240
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.